Clinical Trial

Fast Acute Sedation at Intensive Care vs. High-dose i.v. Anti-seizure Medication for Treatment of Non-convulsive Status Epilepticus (FAST-trial)

Study acronym: FAST
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This open-label, randomized multicenter trial aims at clarifying the standard of care of patients with non-convulsive status epilepticus not responding to treatment with benzodiazepines and at least one high-dose intra venous anti-seizure medication.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-02-21; most recent amendment 2026-05-01.
Trial Details
NCT Number NCT05263674
Lead Sponsor University of Southern Denmark
Collaborators: Aarhus University Hospital, University Hospital of Zealand, Copenhagen University Hospital, Denmark
Conditions Non-Convulsive Status Epilepticus
Enrollment 140 participants
Start Date 2022-02-07
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-04